Company Bafna Pharmaceuticals Limited NSE India S.E.

Equities

BAFNAPH

INE878I01014

Pharmaceuticals

End-of-day quote NSE India S.E. 5-day change 1st Jan Change
- INR -.--% Intraday chart for Bafna Pharmaceuticals Limited +697.75% +207.36%

Business Summary

Bafna Pharmaceuticals Limited is an India-based company, which is engaged in the manufacture of drugs and medicines and selling a reputed brand namely RARICAP. The Company caters to both domestic and international market. It operates in generic pharmaceutical segment. The Company manufactures 336 licensed pharmaceutical formulations and have globally registered 78 of its products. It supplies its products to the United Kingdom, Europe, and Australian markets. The Company's Grantlyon facility has the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. The Company’s subsidiary is Bafna Lifestyles Remedies Limited.

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
851 100.0 % 1,153 100.0 % +35.48%

Sales per region

INR in Million2022Weight2023Weight Delta
India
100.0 %
851 100.0 % 1,153 100.0 % +35.48%

Managers

Managers TitleAgeSince
Chief Executive Officer 62 80-12-31
Director of Finance/CFO - -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 62 80-12-31
Director/Board Member 63 23-06-25
Director/Board Member - -
Chairman - 20-09-09
Director/Board Member - 20-09-09
Director/Board Member 42 23-06-25
Director/Board Member - 20-11-11
Director/Board Member 37 23-06-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 23,656,335 2,419,754 ( 10.23 %) 0 10.23 %

Company contact information

Bafna Pharmaceuticals Ltd.

Bafna Towers No. 68, Thambu Chetty Street

600001, Chennai

+91 44 4267 7555

http://www.bafnapharma.com
address Bafna Pharmaceuticals Limited(BAFNAPH)
  1. Stock Market
  2. Equities
  3. BAFNAPH Stock
  4. BAFNAPH Stock
  5. Company Bafna Pharmaceuticals Limited